Caprotec Bioanalytics
While chemical proteomics has traditionally focused on pharmaceutical work, several recent collaborations suggest that the field is establishing a foothold within agricultural research, as well.
Caprotec Signs Plant Proteomics Research Deal with Syngenta
NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research agreement with Syngenta to profile the interactions of one of Syngenta's active compounds with the proteome of certain relevant plant systems.
Caprotec Enters Second Collaboration with Bayer CropScience for Use of CCMS Technology
NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research collaboration with Bayer CropScience to identify and study an agrochemical target.
BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.
Caprotec, Bayer CropScience Reach Screening Deal
NEW YORK (GenomeWeb News) – Caprotec Bioanalytics has reached an agreement to use its technology to screen an undisclosed new active ingredient from Bayer CropScience.
Sep 16, 2011
Movers & Shakers: Sep 16, 2011
Premium
Jul 15, 2011
Movers & Shakers: Jul 15, 2011
Premium
May 13, 2011
Movers & Shakers: May 13, 2011
Premium
May 9, 2011
Caprotec Raises $1.4M in Series B Round
Oct 8, 2010
Movers & Shakers: Oct 8, 2010
Premium
Oct 8, 2010
New Products: Oct 8, 2010
Premium
Jul 2, 2010
May 14, 2010
Caprotec Raises $5M in Series B Round
Jan 29, 2010
New Products: Jan 29, 2010
Premium
Nov 20, 2009